Page 18 – AAKP

AAKP Innovator Series: Pentec Health

September 2, 2021

In 1983, “PENtech Infusions” began as a small regional pharmacy meeting the needs of dialysis patients and patients with severe pain or spasticity. Over the years, we expanded into a leading provider in both industries.

September 2, 2021

AAKP’s National Patient meeting is an annual convention held in a different city each year, with the exception of the virtual conferences in 2020 and 2021 due to COVID-19.

September 2, 2021

Ayla Maher was diagnosed with cystinosis when she was just two and a half years old. Ayla is now five years old and loves to play, read, work on puzzles, and especially loves creating art!

September 1, 2021

August 31, 2021 The Honorable Chiquita Brooks-LaSure Administrator Centers for Medicare & Medicaid Services Department of Health & Human Services 7500 Security Boulevard Baltimore, MD 21244 RE:

LATE SUMMER READING LIST RELEASED BY LARGEST KIDNEY PATIENT ORGANIZATION

August 27, 2021

FOR IMMEDIATE RELEASE: August 27, 2021 LATE SUMMER READING LIST RELEASED BY LARGEST KIDNEY PATIENT ORGANIZATION Editorials Present Patient Insights on Innovation, Covid-19, Organ Donation, Transplants, and Dialysis Washington, D.C. - The American Association of Kidney Patients (AAKP)

GLOBAL KIDNEY INNOVATION SUMMIT ACCELERATES INTERNATIONAL CONSORTIUM

August 26, 2021

GLOBAL KIDNEY INNOVATION SUMMIT ACCELERATES INTERNATIONAL CONSORTIUM Patient Needs and Insights Drive New Era of Global Kidney Research, Discovery, and Personalized Treatments FOR IMMEDIATE RELEASE August 26, 2021 Washington, D.C. - The American Association of Kidney Patients (AAKP)

AAKP PATIENT IMPACT STATEMENT: FULL FDA APPROVAL OF PFIZER/BIONTECH COVID-19 VACCINE

August 23, 2021

FOR IMMEDIATE RELEASE:

August 20, 2021

August 11, 2021 The Honorable Chiquita Brooks-LaSure Administrator Centers for Medicare and Medicaid Services 200 Independence Avenue Southwest Washington, D.C. 20201 Dear Administrator Brooks-LaSure, As the oldest and largest kidney patient organization in the United States, the American Association of Kidney Patients (AAKP)

NEWS! CDC EMBRACES FDA AUTHORIZATION OF 3RD VACCINE DOSE FOR KIDNEY TRANSPLANT PATIENTS

August 13, 2021

NEWS! CDC EMBRACES FDA AUTHORIZATION OF 3RD VACCINE DOSE FOR KIDNEY TRANSPLANT PATIENTS The American Association of Kidney Patients (AAKP), the nation’s largest patient organization representing kidney transplant patients and living organ donors, thanks the Centers for Disease Control and Prevention (CDC)

AAKP Patient Impact Statement: FDA APPROVAL OF THIRD VACCINE DOSE FOR KIDNEY TRANSPLANT PATIENTS

August 13, 2021

FDA APPROVAL OF THIRD VACCINE DOSE FOR KIDNEY TRANSPLANT PATIENTS PATIENT IMPACT STATEMENT AMERICAN ASSOCIATION OF KIDNEY PATIENTS (AAKP) AMERICA’S LARGEST ORGANIZATION OF KIDNEY TRANSPLANT RECIPIENTS AND LIVING ORGAN DONORS WASHINGTON, D.C.

AAKP Innovator Series: Pentec Health

AAKP Ambassador Sharron Rouse On Why You Should Attend AAKP’s National Patient Meeting

Cystinosis Scholarship Spotlight: Ayla Maher, Summer Art Classes

RE: Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model; CMS-1749-P

LATE SUMMER READING LIST RELEASED BY LARGEST KIDNEY PATIENT ORGANIZATION

GLOBAL KIDNEY INNOVATION SUMMIT ACCELERATES INTERNATIONAL CONSORTIUM

AAKP PATIENT IMPACT STATEMENT: FULL FDA APPROVAL OF PFIZER/BIONTECH COVID-19 VACCINE

AAKP Letter Re: Calcimimetics Drugs 8.12.21

NEWS! CDC EMBRACES FDA AUTHORIZATION OF 3RD VACCINE DOSE FOR KIDNEY TRANSPLANT PATIENTS

AAKP Patient Impact Statement: FDA APPROVAL OF THIRD VACCINE DOSE FOR KIDNEY TRANSPLANT PATIENTS